Catalyst Wire Dossier Catalyst Wire Dossier

REGN1033

· Regeneron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for REGN1033, covering 2012-11-14 to 2024-08-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety, Tolerability, and Pharmacokinetics of REGN2477 Alone and in Combination With REGN1033 in Healthy Postmenopausal Women and Healthy Adult Men [Phase 1]

See pricing